Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Longboard Pharmaceuticals Inc

LBPH
59,98
0,00 (0,00%)
14 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/12/202414:10EDGAR2Form 15-12G - Securities registration termination [Section..
10/12/202421:53EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
10/12/202421:40EDGAR2Form RW WD - Withdrawal of Registration Withdrawal Request
10/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
03/12/202401:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202417:30EDGAR2Form RW - Registration Withdrawal Request
02/12/202415:11EDGAR2Form S-8 POS - Securities to be offered to employees in..
02/12/202415:07EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202415:07EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202415:07EDGAR2Form POS AM - Post-Effective amendments for registration..
02/12/202415:05EDGAR2Form 8-K - Current report
29/11/202414:40EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
20/11/202414:01EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
12/11/202414:30BWLongboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study..
07/11/202422:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:05EDGAR2Form 8-K - Current report
07/11/202422:01BWLongboard Pharmaceuticals Reports Third Quarter 2024..
06/11/202412:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
30/10/202413:57EDGAR2Form SC 14D9 - Solicitation, recommendation statements
22/10/202421:24EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
15/10/202415:17PRNUSKuehn Law Encourages PRMW, FBMS, EVRI, and LBPH Investors to..
15/10/202412:20EDGAR2Form SC14D9C - Written communication relating to third party..
15/10/202412:14EDGAR2Form 8-K - Current report
14/10/202423:47PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
14/10/202412:30BWLundbeck to Acquire Longboard Pharmaceuticals in a Strategic..
04/10/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
26/9/202414:30BWLongboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study..
19/9/202414:30BWLongboard Pharmaceuticals Receives Rare Pediatric Disease..
08/9/202412:30BWLongboard Pharmaceuticals Announces Positive Interim..
06/9/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
28/8/202422:00BWLongboard Pharmaceuticals to Participate in Four Upcoming..
26/8/202422:01BWLongboard Pharmaceuticals to Present Late-Breaking and..
26/8/202415:00BWLongboard Pharmaceuticals to Host Investor & Analyst Event..
02/8/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
01/8/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:10EDGAR2Form 8-K - Current report
01/8/202422:01BWLongboard Pharmaceuticals Reports Second Quarter 2024..
29/7/202415:15BWLongboard Pharmaceuticals to Report Second Quarter 2024..
03/7/202422:00BWLongboard Pharmaceuticals Announces Inducement Grants Under..
01/7/202415:00BWLongboard Pharmaceuticals Receives Breakthrough Therapy..
10/6/202415:05EDGAR2Form 8-K - Current report
10/6/202415:00BWLongboard Pharmaceuticals Announces Positive Interim Results..
03/6/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
24/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 8-K - Current report
06/5/202422:01BWLongboard Pharmaceuticals Announces Inducement Grants Under..
02/5/202422:01BWLongboard Pharmaceuticals Reports First Quarter 2024..
03/4/202415:00BWLongboard Pharmaceuticals to Present Late-Breaking Data from..
02/4/202422:00BWLongboard Pharmaceuticals Announces Inducement Grants Under..
Apertura: Min: Max:
Chiusura: 59,98

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network